Owner MDRNA Research, Inc.

Inventors McSwiggen, James; Ahmadian, Mohammed; Vaish, Narendra K.; Quay, Steven C.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2009212920

Filing date 1 September 2009

Wipo publication date 1 October 2009

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 31/13 (2006.01) - Amines, e.g. amantadine

A61K 31/7105 (2006.01) - Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links

A61K 31/713 (2006.01) - Double-stranded nucleic acids or oligonucleotides

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

C07H 21/00 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07H 21/02 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments